首页> 美国卫生研究院文献>other >Informatics and Computational Methods in Natural Product Drug Discovery: A Review and Perspectives
【2h】

Informatics and Computational Methods in Natural Product Drug Discovery: A Review and Perspectives

机译:天然药物发现中的信息学和计算方法:回顾与展望

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The discovery of new pharmaceutical drugs is one of the preeminent tasks—scientifically, economically, and socially—in biomedical research. Advances in informatics and computational biology have increased productivity at many stages of the drug discovery pipeline. Nevertheless, drug discovery has slowed, largely due to the reliance on small molecules as the primary source of novel hypotheses. Natural products (such as plant metabolites, animal toxins, and immunological components) comprise a vast and diverse source of bioactive compounds, some of which are supported by thousands of years of traditional medicine, and are largely disjoint from the set of small molecules used commonly for discovery. However, natural products possess unique characteristics that distinguish them from traditional small molecule drug candidates, requiring new methods and approaches for assessing their therapeutic potential. In this review, we investigate a number of state-of-the-art techniques in bioinformatics, cheminformatics, and knowledge engineering for data-driven drug discovery from natural products. We focus on methods that aim to bridge the gap between traditional small-molecule drug candidates and different classes of natural products. We also explore the current informatics knowledge gaps and other barriers that need to be overcome to fully leverage these compounds for drug discovery. Finally, we conclude with a “road map” of research priorities that seeks to realize this goal.
机译:在生物医学研究中,科学地,经济地和社会地发现新的药物是一项重要的任务。信息学和计算生物学的进步已在药物开发流程的许多阶段提高了生产率。然而,药物的发现已经减慢了,这在很大程度上是由于对小分子的依赖作为新假说的主要来源。天然产物(例如植物代谢产物,动物毒素和免疫学成分)构成了广泛而多样的生物活性化合物来源,其中一些得到了数千年传统医学的支持,并且与通常使用的小分子分子大相径庭发现。但是,天然产物具有使其与传统小分子候选药物区分开的独特特征,因此需要新的方法和方法来评估其治疗潜力。在这篇综述中,我们研究了生物信息学,化学信息学和知识工程领域的许多最新技术,这些技术可用于从天然产物中发现数据驱动的药物。我们专注于旨在弥合传统小分子候选药物与不同类别的天然产物之间的差距的方法。我们还探索了当前的信息学知识差距和其他障碍,需要充分克服这些障碍才能充分利用这些化合物进行药物开发。最后,我们以寻求实现这一目标的研究重点的“路线图”作为结束。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号